Ranitidine Hydrochloride

Overview

Ranitidine Hydrochloride is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used to treat and prevent ulcers in the stomach and intestines, and conditions such as gastroesophageal reflux disease.

API suppliers (11)

Suppliers of Ranitidine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• PHARMAGLOBE LABORATORIES LTD
• CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
• MAPRIMED SAArgentina GMP on record
• Wockhardt UsaUnited Kingdom
• SHASUN CHEMICALS AND DRUGS LTD
• SOLARA ACTIVE PHARMA SCIENCES LTDIndia GMP on record
• FARCHEMIA SRL
• SMS Pharmaceuticals limitedIndia GMP on record
• RANBAXY LABORATORIES LTD
• SHANGHAI NO 6 PHARMACEUTICAL FACTORY
• QUIMICA SINTETICA SASpain GMP on record

EU CEP holders (2)

Companies holding a valid EU Certificate of Suitability (CEP) for Ranitidine Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Chemical identity

IUPAC name

1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine

Canonical SMILES

CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C

InChIKey

VMXUWOKSQNHOCA-UHFFFAOYSA-N

Therapeutic areas